Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 45451-45500 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06280443
Sarcopenia in Chronic Lung Diseases
N/ARecruiting
300 participants
Started: Nov 25, 2022 · Completed: Sep 30, 2032
4 conditions1 sponsor1 location
NCT05278741
Functional Evaluation After Breast Reconstruction With a Minimally Invasive Latissimus Dorsi Flap Following Radical Surgery for Breast Cancer.
NARecruiting
32 participants
Started: Nov 25, 2022 · Completed: May 25, 2026
1 condition1 sponsor1 location
NCT05430906
AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer
PHASE2Recruiting
40 participants
Started: Nov 25, 2022 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05846373
Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe Migraine
PHASE2Recruiting
66 participants
Started: Nov 25, 2022 · Completed: Jan 10, 2024
1 condition1 sponsor1 location
NCT05588843
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
PHASE2Recruiting
182 participants
Started: Nov 25, 2022 · Completed: Dec 16, 2026
1 condition1 sponsor105 locations
NCT05072262
DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC)
PHASE4Recruiting
300 participants
Started: Nov 25, 2022 · Completed: Oct 31, 2026
2 conditions1 sponsor1 location
NCT06081777
Significance of MRD Monitoring in Patients With Potentially Resectable Stage III Non-small Cell Lung Cancer
N/ARecruiting
65 participants
Started: Nov 25, 2022 · Completed: Jun 1, 2025
1 condition2 sponsors1 location
NCT06183463
The Use of Reconstructive Surgery for Sexually Mutilated Women at the University Hospitals of Strasbourg
N/ARecruiting
29 participants
Started: Nov 24, 2022 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT05645510
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
N/ARecruiting
75 participants
Started: Nov 24, 2022 · Completed: May 30, 2026
10 conditions2 sponsors1 location
NCT06275971
Effectiveness of Continuous Glucose Monitoring System Among Cardiac Surgery Patients
NARecruiting
68 participants
Started: Nov 24, 2022 · Completed: Aug 31, 2024
3 conditions2 sponsors1 location
NCT05699928
Accuracy of Community General Pediatrician Diagnosis of Autism Compared to a Multidisciplinary Team Assessment
N/ARecruiting
200 participants
Started: Nov 24, 2022 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT06365710
Physiotherapy vs Telerehabilitation After Volar Plating of Distal Radius Fracture
NARecruiting
84 participants
Started: Nov 24, 2022 · Completed: Jan 31, 2026
5 conditions1 sponsor1 location
NCT05427448
Validation of Blood Biomarkers for Alzheimer's Disease
NARecruiting
342 participants
Started: Nov 24, 2022 · Completed: Dec 31, 2024
4 conditions1 sponsor3 locations
NCT05309785
Safety and Efficacy of Canagliflozin in Advanced CKD
PHASE4Recruiting
44 participants
Started: Nov 24, 2022 · Completed: Jun 1, 2026
3 conditions1 sponsor1 location
NCT05615077
Multidisciplinary Combined Exercise and Education Intervention for Falls in Older Adults
NARecruiting
484 participants
Started: Nov 24, 2022 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT04983199
Patient Reported Outcomes/Metrics Program Trial
N/ARecruiting
100 participants
Started: Nov 24, 2022 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT05911230
Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases
NARecruiting
10 participants
Started: Nov 24, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05464680
Pulmonary Diffusion of Antibiotics in Patients Admitted for ARDS Following SARS-CoV-2 Pneumonia
NARecruiting
40 participants
Started: Nov 24, 2022 · Completed: Feb 23, 2027
2 conditions1 sponsor1 location
NCT05598684
SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases
N/ARecruiting
600 participants
Started: Nov 24, 2022 · Completed: Dec 30, 2025
5 conditions1 sponsor96 locations
NCT05548621
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
N/ARecruiting
180 participants
Started: Nov 24, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05655897
Safety and Efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation
NARecruiting
120 participants
Started: Nov 24, 2022 · Completed: Nov 24, 2029
2 conditions1 sponsor1 location
NCT05598008
Effects of Glucagon-like-Peptide-1 Analogues on Sexuality
N/ARecruiting
78 participants
Started: Nov 23, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05626387
An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
PHASE4Recruiting
144 participants
Started: Nov 23, 2022 · Completed: Oct 23, 2025
1 condition1 sponsor1 location
NCT06238271
Evaluation of the Long-term Efficacy and Safety of Monofocal Plate Haptic Intraocular Lens
NARecruiting
300 participants
Started: Nov 23, 2022 · Completed: May 31, 2025
2 conditions2 sponsors1 location
NCT05661461
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
PHASE1Recruiting
28 participants
Started: Nov 23, 2022 · Completed: Apr 1, 2025
3 conditions1 sponsor2 locations
NCT05677646
Wearable Sensors for Delirium Detection at an Early Stage (WeSen_delirium)
N/ARecruiting
72 participants
Started: Nov 23, 2022 · Completed: Sep 30, 2025
1 condition2 sponsors2 locations
NCT05917158
A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma
PHASE2Recruiting
30 participants
Started: Nov 23, 2022 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT06024187
Cold Dissection Versus Electrocautery Dissection in Endoscopic Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction: A Randomized Controlled Trial
NARecruiting
566 participants
Started: Nov 23, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05410730
A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC
PHASE1/PHASE2Recruiting
150 participants
Started: Nov 23, 2022 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT05398003
Medullary Stimulation for the Treatment of Refractory Neck Pain (S2M)
NARecruiting
12 participants
Started: Nov 23, 2022 · Completed: Sep 23, 2026
1 condition1 sponsor1 location
NCT04797299
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)
N/ARecruiting
526 participants
Started: Nov 23, 2022 · Completed: Nov 30, 2035
1 condition1 sponsor24 locations
NCT05225233
tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity
NARecruiting
124 participants
Started: Nov 23, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05412771
Evolutive and Functional Bases of Menstruation in Women - 2
NARecruiting
20 participants
Started: Nov 23, 2022 · Completed: Oct 25, 2027
1 condition1 sponsor1 location
NCT05226455
Venetoclax in Patients With MDS or AML in Relapse After AHSCT
PHASE1/PHASE2Recruiting
55 participants
Started: Nov 23, 2022 · Completed: Dec 1, 2027
2 conditions2 sponsors13 locations
NCT05087303
Telemedicine for Children With Sickle Cell Disease
NARecruiting
60 participants
Started: Nov 23, 2022 · Completed: Jan 1, 2026
1 condition2 sponsors1 location
NCT05621746
An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct
N/ARecruiting
100 participants
Started: Nov 23, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05626621
Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis
PHASE4Recruiting
81 participants
Started: Nov 23, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05739084
Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS
N/ARecruiting
300 participants
Started: Nov 23, 2022 · Completed: Nov 23, 2025
1 condition1 sponsor1 location
NCT05656131
Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer
PHASE2Recruiting
80 participants
Started: Nov 23, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05451212
Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
PHASE1Recruiting
24 participants
Started: Nov 23, 2022 · Completed: Oct 31, 2028
1 condition1 sponsor5 locations
NCT05694559
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
NARecruiting
1,000 participants
Started: Nov 23, 2022 · Completed: Feb 2, 2027
2 conditions1 sponsor1 location
NCT06154343
A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors
PHASE1Recruiting
150 participants
Started: Nov 23, 2022 · Completed: Jul 30, 2025
1 condition1 sponsor20 locations
NCT05613738
177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer
NARecruiting
9 participants
Started: Nov 23, 2022 · Completed: Nov 15, 2025
1 condition1 sponsor1 location
NCT05606692
Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics)
PHASE4Recruiting
416 participants
Started: Nov 23, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT05965245
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
NARecruiting
278 participants
Started: Nov 23, 2022 · Completed: Aug 31, 2027
2 conditions2 sponsors2 locations
NCT06313411
How do I Perform a Laparoscopic Removal of a Pelvic Retroperitoneal Schwannoma
N/ARecruiting
1 participants
Started: Nov 23, 2022 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT05619016
[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors
PHASE2Recruiting
72 participants
Started: Nov 23, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06491082
Chemotherapy Induced Neuropathy in Cancer Patients
N/ARecruiting
124 participants
Started: Nov 23, 2022 · Completed: Aug 25, 2024
1 condition1 sponsor1 location
NCT05788679
A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS
PHASE2Recruiting
200 participants
Started: Nov 22, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05579548
A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding
N/ARecruiting
50 participants
Started: Nov 22, 2022 · Completed: Oct 4, 2032
1 condition2 sponsors3 locations